How Much Does Latisse Cost? Med Spa vs Pharmacy vs Generic

Latisse (bimatoprost ophthalmic solution 0.03%, Allergan/AbbVie) is the drug the FDA approved on December 24, 2008, for hypotrichosis of the eyelashes — inadequate or not enough lashes — and it is a product you take home and apply yourself, not an in-clinic service.

The label lists two kit sizes in the US: 3 mL of solution (in a 5 mL bottle) with 70 disposable applicators, and 5 mL with 140 applicators.

The applicators are part of the product; the carton counts them out, and the directions use a fresh one for each eye every night.

What the bottle costs is the part we cannot confirm.

The label we checked carries no list price, and RealSelf and GoodRx were blocked or not usable in our research.

We could not verify a price for either kit size at any channel, so any dollar figure you see quoted — including online averages — is unverified as far as this page is concerned.

Ask each seller for its current per-kit price.

Two things change between quotes: the kit size, and brand versus generic bimatoprost 0.03% — more on the generic below.

Where the prescription is filled is the next section's subject.

One money detail is published, and it is not a price: Allē, the rewards program that lists Latisse among its eligible products, publishes base earn rates of 50 to 150 points per kit (Allē's own published rates, read October 2026).

Points are not dollars, so treat the earn rate as a loyalty detail, not a price.

Every channel starts in the same place: a prescription.

The Latisse carton is marked "Rx only", so a licensed prescriber has to write it, and neither the brand nor its generics is an over-the-counter product.

The setting of the prescriber's office — a med spa, a dermatology practice, a pharmacy clinic — changes who you see, not what the product is.

There is also no procedure to pay for.

The treatment happens at home: once nightly, one drop on a new sterile single-use applicator brushed along the upper eyelid margin at the base of the lashes, a fresh applicator for the other eye, never on the lower lash line.

There is no in-clinic session for a med spa to perform — its role is the prescription.

Who may prescribe and dispense inside a med spa is set by state law, so ask the practice directly who will write your prescription.

Online, the same rule applies: a seller offering "Latisse" without a prescription is not following the carton's "Rx only" labeling.

Over-the-counter lash serums are a different product category altogether — they are not Latisse and do not carry its prescription-drug label.

The product you would be substituting away from is a drug with its own trial record: in the label's 278-patient, 4-month trial, the most common reactions — eye itching, eye redness, skin darkening, eye irritation, dry eye symptoms and eyelid redness — each occurred in fewer than 4% of patients.

Yes.

FDA-approved generic bimatoprost ophthalmic solution 0.03% exists for the same eyelash hypotrichosis indication as the brand.

The examples in our research are Sandoz (ANDA 202719) and Alembic (ANDA 210515), and those generics are also prescription-only — you need a prescription for them, as for the brand.

What we can't tell you is the price gap.

Our research did not verify prices for the brand or the generics, so any "the generic is cheaper" figure you find is unverified as far as this page is concerned.

The workable move is unglamorous: ask the pharmacy to quote brand and generic side by side, and check what each price includes — bottle size and applicators.

One substitution to rule out: bimatoprost is also approved as a glaucoma treatment at a different strength.

That eye-drop product is not the lash treatment, and nothing in the research behind this page supports using glaucoma bimatoprost drops on your lashes.

The eyelash products are the 0.03% solutions, brand and generic alike.

The label does not state how long a bottle lasts, but its contents and directions let you do the arithmetic.

The directions are once nightly: one drop on a new sterile single-use applicator for one eye, a fresh applicator for the other.

That is two applicators per night, and the kits are packed to match — 70 applicators with the 3 mL kit, 140 with the 5 mL kit.

So the 70-applicator kit covers 35 nights of labeled use, and the 140-applicator kit covers 70 — arithmetic from the label's contents, not a labeled statement of duration.

How long your own kit lasts is a question for your prescriber, especially if your instructions differ from the label's default.

The money-relevant timing is in the trial data.

Onset is gradual — the label says it is not significant in most patients until 2 months — and the pivotal trial measured its primary endpoint at week 16, where 78% of Latisse users had at least a 1-grade improvement in eyelash prominence, against 18% on the vehicle control.

In money terms, that is a recurring kit purchase over months of use, not a one-off fee.

The label is also plain that the effect is not permanent: when treatment stops, eyelash growth is expected to return to its pre-treatment level.

There is no procedure fee around the kit, but ask whether the prescriber's visit is charged separately; the kit purchase recurs for as long as the treatment continues.

Because the product is prescription-only, the practical path is short: a licensed prescriber writes the prescription, and it is filled at a pharmacy — or dispensed by the practice, where state law allows.

Who may prescribe and dispense inside a med spa is state law, so make the question explicit when you call — ask who will write the prescription and where the kit comes from.

For what the drug is approved for, how results behaved in the label's trial and the side effects and risks, our Latisse guide covers the drug itself; this page stays on the money.